Monoaminergic System Modulation in Depression and Alzheimer's Disease: A New Standpoint?
The prevalence of depression has dramatically increased, and it has been estimated that over 300 million people suffer from depression all over the world. Depression is highly comorbid with many central and peripheral disorders. In this regard, depressive states have been associated with the develop...
Saved in:
Main Authors: | Maria Grazia Morgese (Author), Luigia Trabace (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2019-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Precision Medicine in Alzheimer's Disease: Investigating Comorbid Common Biological Substrates in the Rat Model of Amyloid Beta-Induced Toxicity
by: Maria Grazia Morgese, et al.
Published: (2022) -
Editorial: New players on the monoaminergic field: relevance to the mental disorders
by: Eliyahu Dremencov, et al.
Published: (2024) -
Glucoraphanin Triggers Rapid Antidepressant Responses in a Rat Model of Beta Amyloid-Induced Depressive-like Behaviour
by: Paolo Tucci, et al.
Published: (2022) -
N-3 PUFA Prevent Oxidative Stress in a Rat Model of Beta-Amyloid-Induced Toxicity
by: Maria Grazia Morgese, et al.
Published: (2021) -
Home Problems from a New Standpoint
by: Hunt, Caroline Louisa, 1865-1927